3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Sarcoma
5
Neoplasm Metastasis
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Rectal Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hyperthermia
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Ovarian Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Metabolic Syndrome
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Interventions
Metformin
91
Clomiphene
31
Letrozole
23
Inositol
19
Folic Acid
11
Chorionic Gonadotropin
11
Exercise
10
High-Intensity Interval Training
9
drospirenone and ethinyl estradiol combination
8
Ethinyl Estradiol
8
Contraceptives, Oral
8
Cholecalciferol
8
cetrorelix
7
Tablets
7
Progesterone
7
Menotropins
6
follitropin alfa
5
Pioglitazone
5
Liraglutide
5
Exenatide
5
Cyproterone Acetate
5
Caloric Restriction
5
Vitamin D
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Sugars
4
Spironolactone
4
Glycoprotein Hormones, alpha Subunit
4
Fish Oils
4
Estradiol
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycystic Ovary Syndrome
×
Diathermy
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled